222 related articles for article (PubMed ID: 28912543)
1. Inhibition of fucosylation by 2-fluorofucose suppresses human liver cancer HepG2 cell proliferation and migration as well as tumor formation.
Zhou Y; Fukuda T; Hang Q; Hou S; Isaji T; Kameyama A; Gu J
Sci Rep; 2017 Sep; 7(1):11563. PubMed ID: 28912543
[TBL] [Abstract][Full Text] [Related]
2. Comparison of two glycoengineering strategies to control the fucosylation of a monoclonal antibody.
Mishra N; Spearman M; Donald L; Perreault H; Butler M
J Biotechnol; 2020; 324S():100015. PubMed ID: 34154738
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of fucosylation by 2-fluorofucose attenuated acetaminophen-induced liver injury
Liu Z; Tu M; Shi J; Zhou H; Meng G; Gu J; Wang Y
Front Pharmacol; 2022; 13():939317. PubMed ID: 36120347
[TBL] [Abstract][Full Text] [Related]
4. Cellular Fucosylation Inhibitors Based on Fluorinated Fucose-1-phosphates*.
Pijnenborg JFA; Visser EA; Noga M; Rossing E; Veizaj R; Lefeber DJ; Büll C; Boltje TJ
Chemistry; 2021 Feb; 27(12):4022-4027. PubMed ID: 33336886
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic and Prophylactic Antitumor Activity of an Oral Inhibitor of Fucosylation in Spontaneous Mammary Cancers.
Disis ML; Corulli LR; Gad EA; Koehnlein MR; Cecil DL; Senter PD; Gardai SJ; Okeley NM
Mol Cancer Ther; 2020 May; 19(5):1102-1109. PubMed ID: 32165557
[TBL] [Abstract][Full Text] [Related]
6. 2-Fluorofucose Attenuates Hydrogen Peroxide-Induced Oxidative Stress in HepG2 Cells via Nrf2/keap1 and NF-κB Signaling Pathways.
Tu M; Fan X; Shi J; Jing S; Xu X; Wang Y
Life (Basel); 2022 Mar; 12(3):. PubMed ID: 35330157
[TBL] [Abstract][Full Text] [Related]
7. The fucosylation inhibitor, 2-fluorofucose, inhibits vaso-occlusion, leukocyte-endothelium interactions and NF-ĸB activation in transgenic sickle mice.
Belcher JD; Chen C; Nguyen J; Abdulla F; Nguyen P; Nguyen M; Okeley NM; Benjamin DR; Senter PD; Vercellotti GM
PLoS One; 2015; 10(2):e0117772. PubMed ID: 25706118
[TBL] [Abstract][Full Text] [Related]
8. An Alkynyl-Fucose Halts Hepatoma Cell Migration and Invasion by Inhibiting GDP-Fucose-Synthesizing Enzyme FX, TSTA3.
Kizuka Y; Nakano M; Yamaguchi Y; Nakajima K; Oka R; Sato K; Ren CT; Hsu TL; Wong CH; Taniguchi N
Cell Chem Biol; 2017 Dec; 24(12):1467-1478.e5. PubMed ID: 29033318
[TBL] [Abstract][Full Text] [Related]
9. Core fucosylation regulates epidermal growth factor receptor-mediated intracellular signaling.
Wang X; Gu J; Ihara H; Miyoshi E; Honke K; Taniguchi N
J Biol Chem; 2006 Feb; 281(5):2572-7. PubMed ID: 16316986
[TBL] [Abstract][Full Text] [Related]
10. Decreased core-fucosylation contributes to malignancy in gastric cancer.
Zhao YP; Xu XY; Fang M; Wang H; You Q; Yi CH; Ji J; Gu X; Zhou PT; Cheng C; Gao CF
PLoS One; 2014; 9(4):e94536. PubMed ID: 24732908
[TBL] [Abstract][Full Text] [Related]
11. Site-specific glycoproteomic analysis revealing increased core-fucosylation on FOLR1 enhances folate uptake capacity of HCC cells to promote EMT.
Jia L; Li J; Li P; Liu D; Li J; Shen J; Zhu B; Ma C; Zhao T; Lan R; Dang L; Li W; Sun S
Theranostics; 2021; 11(14):6905-6921. PubMed ID: 34093861
[No Abstract] [Full Text] [Related]
12. Aberrant fucosylation sustains the NOTCH and EGFR/NF-κB pathways and has a prognostic value in human intrahepatic cholangiocarcinoma.
Ament CE; Steinmann S; Evert K; Pes GM; Ribback S; Gigante I; Pizzuto E; Banales JM; Rodrigues PM; Olaizola P; Wang H; Giannelli G; Chen X; Evert M; Calvisi DF
Hepatology; 2023 Dec; 78(6):1742-1754. PubMed ID: 36789652
[TBL] [Abstract][Full Text] [Related]
13. Development of orally active inhibitors of protein and cellular fucosylation.
Okeley NM; Alley SC; Anderson ME; Boursalian TE; Burke PJ; Emmerton KM; Jeffrey SC; Klussman K; Law CL; Sussman D; Toki BE; Westendorf L; Zeng W; Zhang X; Benjamin DR; Senter PD
Proc Natl Acad Sci U S A; 2013 Apr; 110(14):5404-9. PubMed ID: 23493549
[TBL] [Abstract][Full Text] [Related]
14. Relationship between elevated FX expression and increased production of GDP-L-fucose, a common donor substrate for fucosylation in human hepatocellular carcinoma and hepatoma cell lines.
Noda K; Miyoshi E; Gu J; Gao CX; Nakahara S; Kitada T; Honke K; Suzuki K; Yoshihara H; Yoshikawa K; Kawano K; Tonetti M; Kasahara A; Hori M; Hayashi N; Taniguchi N
Cancer Res; 2003 Oct; 63(19):6282-9. PubMed ID: 14559815
[TBL] [Abstract][Full Text] [Related]
15. Synthetic Fluorinated l-Fucose Analogs Inhibit Proliferation of Cancer Cells and Primary Endothelial Cells.
Dai Y; Hartke R; Li C; Yang Q; Liu JO; Wang LX
ACS Chem Biol; 2020 Oct; 15(10):2662-2672. PubMed ID: 32930566
[TBL] [Abstract][Full Text] [Related]
16. Eriodictyol suppresses the malignant progression of colorectal cancer by downregulating tissue specific transplantation antigen P35B (TSTA3) expression to restrain fucosylation.
Huang H; He Y; Li Y; Gu M; Wu M; Ji L
Bioengineered; 2022 Mar; 13(3):5551-5563. PubMed ID: 35184647
[TBL] [Abstract][Full Text] [Related]
17. Core fucosylation of N-linked glycans in leukocyte adhesion deficiency/congenital disorder of glycosylation IIc fibroblasts.
Sturla L; Fruscione F; Noda K; Miyoshi E; Taniguchi N; Contini P; Tonetti M
Glycobiology; 2005 Oct; 15(10):924-34. PubMed ID: 15917429
[TBL] [Abstract][Full Text] [Related]
18. Fucosyltransferase 8 deficiency suppresses breast cancer cell migration by interference of the FAK/integrin pathway.
Liu D; Gao Z; Yue L
Cancer Biomark; 2019; 25(4):303-311. PubMed ID: 31306109
[TBL] [Abstract][Full Text] [Related]
19. FUT8 promotes breast cancer cell invasiveness by remodeling TGF-β receptor core fucosylation.
Tu CF; Wu MY; Lin YC; Kannagi R; Yang RB
Breast Cancer Res; 2017 Oct; 19(1):111. PubMed ID: 28982386
[TBL] [Abstract][Full Text] [Related]
20. Expression of genes that control core fucosylation in hepatocellular carcinoma: Systematic review.
Norton PA; Mehta AS
World J Gastroenterol; 2019 Jun; 25(23):2947-2960. PubMed ID: 31249452
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
